The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to Raise £0.41 Million

14 Jun 2018 07:00

RNS Number : 3357R
Location Sciences Group PLC
14 June 2018
 

 14 June 2018

Location Sciences Group PLC

("Location Sciences" or the "Company")

Placing to raise £0.41 million

Location Sciences Group PLC (AIM: LSAI), the leading mobile location data and intelligence expert, is pleased to announce that it has raised, in aggregate, £412,372 before expenses by way of a placing of 1,374,574,705 new ordinary shares of 0.01 pence each (the "Ordinary Shares") (the "Placing") at 0.03 pence per share (the "Issue Price"). The Placing is conditional on admission of the new Ordinary Shares to trading on AIM ("Admission").

The Issue Price represents a discount of approximately 13.04 per cent. to the closing price of 0.0345 pence per share on 13 June 2018, the last business day prior to the date of this announcement, and a premium of approximately 8.21 per cent. to the Company's 60-day average closing price. The net proceeds of the Placing will be used primarily to invest in and market the Company's new location verification product, Verify, and for 2018 working capital purposes.

Location data is increasingly becoming a mainstream marketing tool, with advertisers seeking greater transparency from agencies and publishers as well as alternatives to the walled worlds of Facebook and Google. This shift in the advertising industry underlines the market opportunity for Verify, which promotes transparency across the supply chain and guarantees accurate independent verification of location data.

The directors of the Company (the "Directors") are pleased to report that Verify, with its first mover advantage, is already gaining market traction and the Company's panel of seven million consumers is proving to be attractive to a wide range of organisations looking to maximise the impact of their digital spend.

Following the Placing, the Directors are confident that the Company now has the platform to seize the exciting opportunity for location verification, and believe this will become an increasingly important element of Location Sciences' business as this market grows in the UK and Europe.

Furthermore, the Directors have conducted a review of the UK's location data and insights market which has highlighted possible acquisition opportunities for the Company. Any material acquisition will be subject to shareholder approval at a general meeting and will only be progressed if it both solidifies the Company's market leading position in the UK and improves the underlying financial performance of the Company.

The Directors are excited about the opportunities in the UK market and will keep shareholders informed as their strategy progresses.

Related Party Transaction

Peel Hunt LLP ("Peel Hunt") is participating in the Placing. The participation of Peel Hunt, a substantial shareholder in the Company, is a related party transaction per Rule 13 of the AIM Rules. Accordingly, the Directors, having consulted with Stockdale Securities Limited, the Company's nominated adviser, consider that the terms and conditions of Peel Hunt's participation in the Placing are fair and reasonable insofar as the shareholders of the Company are concerned.

Application for Admission

Application has been made to the London Stock Exchange for the admission of the new Ordinary Shares to trading on AIM. It is expected that Admission will occur and that dealings will commence at 8.00 a.m. on 19 June 2018 at which time it is also expected that the new Ordinary Shares will be enabled for settlement in CREST.

Following Admission, the number of Ordinary Shares in issue will be 15,120,321,774. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Commenting Mark Slade, CEO of Location Sciences, said: "I am pleased to announce the completion of a successful fundraising to support the on-going marketing and commercialisation of our Verify product. It is pleasing that the Placing was over-subscribed and that the Directors are able to issue the maximum number of shares authorised by our shareholders. It's important for us to capitalise on our first mover advantage and with these new funds I am confident in gaining significant market traction over the coming months."

  

End

Enquiries:

 

Location Sciences Group PLC

Via Redleaf Communications

Mark Slade, Chief Executive Officer

David Rae, Chief Financial Officer

 

 

 

Stockdale Securities Limited

Tel: +44 (0)20 7601 6100

Andy Crossley

Tom Griffiths

 

Ed Thomas

 

 

 

Redleaf Communications

Tel: +44 (0) 20 3757 6880

Charlie Geller

 

Fiona Norman

 

 

About Location Sciences Group PLC:

· Location Sciences helps companies connect the online world with the offline world using mobile location technology data. We combine cutting-edge mobile location data collection with proprietary machine learning analytics to create new value and insights from location information.

 

· Location Sciences is media-agnostic and work with a variety of media, advertising, technology partners - plus the world's biggest brands. Our technology is well positioned to fulfil the need for greater accuracy and accountability in a growing market that is increasingly looking for superior data and verification.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIEAXKDFFSPEFF
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.